166 related articles for article (PubMed ID: 6188282)
1. [Recent developments in chemotherapy of malignant diseases].
Moser K; Pohl A
Wien Klin Wochenschr; 1982 Dec; 94(23):640-8. PubMed ID: 6188282
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of Hodgkin disease with modified MOPP].
Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
[No Abstract] [Full Text] [Related]
3. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
4. [Cytostatic chemotherapy in lymphogranulomatosis].
Stacher A
Med Klin; 1973 Jul; 68(30):985-8. PubMed ID: 4131695
[No Abstract] [Full Text] [Related]
5. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
6. Chemotherapy in the treatment of malignant brain tumors.
Walker MD; Weiss HD
Adv Neurol; 1975; 13():149-191. PubMed ID: 130061
[No Abstract] [Full Text] [Related]
7. Varicella in immunodepressed children.
Moe PJ
Postgrad Med J; 1985; 61 Suppl 4():15-6. PubMed ID: 3869844
[TBL] [Abstract][Full Text] [Related]
8. [Remission with antineoplastic agents?].
Ersbøll J
Ugeskr Laeger; 1989 Jul; 151(29):1885-6. PubMed ID: 2773106
[No Abstract] [Full Text] [Related]
9. [Treatment of lymphogranulomatosis].
Baĭsogolov GD
Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
[No Abstract] [Full Text] [Related]
10. [Combined therapy of lymphogranulomatosis].
Vorob'ev AI; Fokina NT; Brilliant MD; Fil'kova EM
Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):3-7. PubMed ID: 6895412
[No Abstract] [Full Text] [Related]
11. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
[No Abstract] [Full Text] [Related]
12. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
14. [Treatment of recurrences of lymphogranulomatosis].
Kovryzhkina TA
Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
[No Abstract] [Full Text] [Related]
15. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in children with Hodgkin disease.
Celkan T; Yildiz I
Pediatr Blood Cancer; 2008 Nov; 51(5):712; author reply 712-3. PubMed ID: 18668513
[No Abstract] [Full Text] [Related]
17. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Kolygin BA; Kharatishvili ZV
Vopr Onkol; 1983; 29(8):12-5. PubMed ID: 6688487
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
Melato M; Falconieri G; Giammarini Barsanti A; Mottola A
Haematologica; 1983; 68(5):675-9. PubMed ID: 6416946
[No Abstract] [Full Text] [Related]
19. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
Shapiro WR; Young DF
Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
[No Abstract] [Full Text] [Related]
20. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]